Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision, Affymetrix, Quest Diagnostics, Iconix Biosciences, Syngene

Belgian pharmacogenomic lab DNAVision this week said that it will now offer Affymetrix’s Genome-Wide Human SNP Array 6.0. DNAVision claims to be the first full-service PGx lab to provide the SNP Array 6.0 in Europe.

Quest Diagnostics is now offering a molecular diagnostic test that can detect chromosome abnormalities associated with 85 developmental disorders affecting children, the firm said last week.
The test, ClariSure is an array comparative genomic hybridization test that will be used to diagnose patients with mental retardation and Down syndrome among other disorders. Quest said it expects to provide physicians with test results within five days of receiving specimens at one of its facilities.
The test is based on technologies developed by Quest’s Nichols Institute and other licensed methodologies.

Iconix Biosciences last month launched DrugMatrix Online 1.0, which provides users with web-based access to a full-featured version of its DrugMatrix database.
According to Iconix, researchers can access DrugMatrix Online from any location using only a personal computer. DrugMatrix Online allows licensed users to securely upload Affymetrix gene expression data from the Rat 230 2.0, RAE230A, or RGU34A GeneChips and obtain a drug signature similarity scoring as well as extensive comparative data from a collection of reference information on rats treated with more than 500 reference drugs and toxicants.

Syngene, an imaging company, said this week that two of its G:BOX multi-application imaging systems have shown “excellent performance” with SuperArray Bioscience’s Oligo GEArrays.
According to Syngene, researchers at SuperArray Bioscience evaluated their Oligo GEArrays using the G:BOX Chemi HR16 and G:BOX Chemi XT16 imaging systems. They found using a G:BOX Chemi HR16, they could image eight arrays simultaneously and with the G:BOX Chemi XT16, 32 arrays at the same time.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.